Your browser doesn't support javascript.
loading
Endoplasmic reticulum oxidoreductase 1 alpha modulates prostate cancer hallmarks.
Cornelius, Julian; Cavarretta, Ilaria; Pozzi, Edoardo; Lavorgna, Giovanni; Locatelli, Irene; Tempio, Tiziana; Montorsi, Francesco; Mattei, Agostino; Sitia, Roberto; Salonia, Andrea; Anelli, Tiziana.
  • Cornelius J; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Cavarretta I; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
  • Pozzi E; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Lavorgna G; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Locatelli I; University Vita-Salute San Raffaele, Milan, Italy.
  • Tempio T; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Montorsi F; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Mattei A; Division of Genetics and Cell Biology, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Sitia R; Division of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
  • Salonia A; University Vita-Salute San Raffaele, Milan, Italy.
  • Anelli T; Department of Urology, Luzerner Kantonsspital, Lucerne, Switzerland.
Transl Androl Urol ; 10(3): 1110-1120, 2021 Mar.
Article en En | MEDLINE | ID: mdl-33850746